Zirgan Ophthalmic Gel 0.15pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Zirgan: Ophthalmic gel (0.15%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Zirgan Ophthalmic Gel
Drug Image file default-drug-image.png
Zirgan Ophthalmic Gel

What is this Medicine?

GANCICLOVIR (gan SYE kloe veer) is an antiviral medicine. It is used to treat herpes infection in the eye.

CVS Pharmacy Patient Statistics for Zirgan: Ophthalmic gel(0.15%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Zirgan 0.15% Ophthalmic Gel

NDC: 242080535
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Herpes Simplex Keratitis (dendritic Keratitis)

Storage Information
Do not freeze
Store between 59 to 77 degrees F
Zirgan 0.15% Ophthalmic Gel

Reported Side Effects for Zirgan 0.15% Ophthalmic Gel

Endophthalmitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Red Eyes Incidence:
5.0%*
Severity: MODERATE
Onset: EARLY
Eye Inflammatoin Incidence:
>5.0%*
Severity: SEVERE
Onset: DELAYED
Eye Irritation Incidence:
20.0%*
Severity: MILD
Onset: RAPID
Blurred Vision Incidence:
60.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Zirgan

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5